BALIOPHARM
Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.
BALIOPHARM
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Jülich, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.baliopharm.com
Total Employee:
11+
Status:
Active
Contact:
+49 2461 6210 855
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS PHP Debian Apache 2.2
Similar Organizations
Actigen Ltd
Actigen Ltd is an biotechnology company engaged in the development of human antibody therapeutics.
Alix
Alix SA is a biotechnology company that develops drugs for the identification of therapeutic targets.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
CytoTools
CytoTools AG is a biotechnology company focused on translating fundamental biology research .
De Western Therapeutics Institute
De Western Therapeutics Institute is a biotechnology company that focuses on development of innovative new drags to serve patients worldwide
NatImmune A/S
NatImmune A/S operates a biotech company focusing on the development of protein-based therapeutics.
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Current Employees Featured
Heimo Stroissnig Chief Marketing Officer @ Baliopharm
Chief Marketing Officer
Andreas Herrmann CEO and Founder @ Baliopharm
CEO and Founder
2011-09-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-07-05 | 3Z Pharmaceuticals | Baliopharm investment in Seed Round - 3Z Pharmaceuticals | 400 K USD |
Official Site Inspections
http://www.baliopharm.com Semrush global rank: 11.9 M Semrush visits lastest month: 143
- Host name: www.baliopharm.de
- IP address: 217.113.46.166
- Location: Berlin Germany
- Latitude: 52.5238
- Longitude: 13.4428
- Timezone: Europe/Berlin
- Postal: 10249
More informations about "Baliopharm"
Company Profile - Baliopharm
Baliopharm was founded in 2006 as Celonic AG, a service company for the contract development and manufacturing of biopharmaceutical compounds, based on the operations founded 1998 in Germany (Celonic GmbH). In 2009, …See details»
Baliopharm - Crunchbase Company Profile & Funding
Organization. Baliopharm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Baliopharm AG is a biotechnology company focusing …See details»
Board of Directors - Baliopharm
In 2011 the service unit of Celonic AG was sold and the remaining part focusing on the development of therapeutic antibodies renamed to Baliopharm AG (Basel). To further support the research activities, Baliopharm GmbH was founded in …See details»
Baliopharm AG - Swiss Biotech
Baliopharm AG, is a biotechnology company focusing on the development of innovative therapeutics for the treatment of chronic liver diseases, immune mediated inflammatory …See details»
Baliopharm Company Profile - Office Locations, Competitors
Baliopharm is a biotechnology company focusing on the treatment of acute and chronic diseases. It develops therapeutics for chronic liver diseases, immune mediated inflammatory diseases, …See details»
Baliopharm - Overview, News & Similar companies | ZoomInfo.com
Jan 7, 2021 Who is Baliopharm. Baliopharm AG is a biotechnology company focusing on the development of novel antibody-based therapeutics for the treatment of autoimmune diseases …See details»
Baliopharm Company Profile 2024: Valuation, Investors …
Baliopharm General Information Description. Developer of biotechnological therapeutic drugs based in Basel, Switzerland. The company's products include therapeutics for the treatment of autoimmune diseases like rheumatoid …See details»
Baliopharm - Products, Competitors, Financials, Employees, …
Baliopharm is a biotechnology company focusing on the development of biosimilar therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn's disease, psoriasis …See details»
Baliopharm - Funding, Financials, Valuation & Investors
Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... Which …See details»
Alvotech Completes Acquisition of Baliopharm | Alvotech
Baliopharm will be fully integrated into the Alvotech organization and will be rebranded as Alvotech Germany in the near future. Eef Schimmelpennink, CEO of Alvotech, said: “The …See details»
Acquisition of Baliopharm - Alvotech - Better Access …
May 18, 2016 Baliopharm will be fully integrated into the Alvotech organization and will be rebranded as Alvotech Germany in the near future. Eef Schimmelpennink, CEO of Alvotech, said: “The acquisition of Baliopharm …See details»
Baliopharm - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024 Organization. Baliopharm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 9. Monthly …See details»
Promethera Biosciences Acquires Baliopharm AG to Strengthen its ...
Apr 10, 2018 Dr. Andreas Herrmann, CEO of Baliopharm commented, “Today’s announcement is a testament to the strong science that is the foundation of our next-generation anti-TNF R1 …See details»
Promethera Biosciences Acquires Baliopharm AG to Strengthen its ...
Apr 11, 2018 Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced that it has acquired Baliopharm AG, a Swiss biopharmaceutical …See details»
Alvotech Completes Acquisition of Baliopharm
Baliopharm will be fully integrated into the Alvotech organization and will be rebranded as Alvotech Germany in the near future. Eef Schimmelpennink, CEO of Alvotech, said: The …See details»
Promethera Biosciences Acquires Baliopharm AG to Strengthen its ...
Apr 10, 2018 Baliopharm was founded in 2011 as a spin-off of Celonic AG, an internationally operating service provider in the area of contract development and manufacturing of …See details»
Strategy - Baliopharm
Beyond that, Baliopharm develops these compounds as well as Novotarg for other autoimmune and tumor diseases. It is the intention of Baliopharm to develop these drug candidates at a …See details»
Baliopharm successfully completed a phase 1 trial of Atrosimab, a …
Baliopharm successfully completed a phase 1 trial of Atrosimab, a TNFR1-selective antagonistic monovalent antibody derivative developed at IZI June 7, 2022 Read the news on fuw.chSee details»
Baliopharm - Contacts, Employees, Board Members, Advisors
Organization. Baliopharm . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Baliopharm has 2 …See details»
Product Pipeline / Overview - Baliopharm
Baliopharm approaches the treatment of inflammatory diseases with its drug candidates Atrosab and Atrosimab, which both specifically target the pro-inflammatory tumor necrosis factor …See details»